Dr Ruth DobsonClinical Reader in NeurologyEmail: ruth.dobson@qmul.ac.ukProfilePublicationsSupervisionProfileI am a Consultant Neurologist with extensive experience in multiple sclerosis and related disorders. I currently lead a number of research projects including a multi-centre pharmacovigilance study in MS (OPTIMISE:MS), the UK MS Pregnancy Register, and a multi-ethnic genetics study in MS (ADAMS). I am interested in the role of modifiable factors such as Epstein Barr virus and vitamin D in the development of MS and its subsequent complications, and am using routinely acquired healthcare data to better understand this. I have been awarded research grants from MS Society, NMSS, BMA Foundation, MRC and NIHR. I studied at Clare College Cambridge before graduating with distinction in clinical sciences from University College London. I completed her PhD in 2013, having received funding from the Guarantors of Brain and an MS Society/ABN Clinical Research fellowship for this work. I have been awarded numerous scholarships, and was an RCP Emerging Female Leader fellow in 2019. I have a keen interest in equality and diversity, both within MS and the wider academic field. I lead national and international mentorship schemes, and am a non-executive board member of International Women in MS. I am deputy Academic Lead for EDI within QMUL Faculty of Medicine and Dentistry, and sit on the FMD Athena Swan committee. I have also provided input into EDI strategies for external organisations, such as the MS Society. Outside of work I spend much of my time looking after my two daughters, and enjoy swimming and playing the cello when I get a chance.ResearchPublicationsKey Publications COVID-19 Vaccine Response in People with Multiple Sclerosis Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines Jacobs BM, Daruwalla C, McKeon MO et al. (2023). Early depressive symptoms and disability accrual in Multiple Sclerosis: a UK MS Register study. nameOfConference DOI: 10.1038/s41598-023-34545-6 QMRO: qmroHref Jacobs BM, Schalk L, Dunne A et al. (2023). ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK. nameOfConference DOI: 10.1136/bmjopen-2023-071656 QMRO: qmroHref Oreja-Guevara C, Vukusic S, Pietrasanta C et al. (2023). Données de grossesses et des enfants de femmes recevant ocrélizumab pour le traitement de la sclérose en plaques. nameOfConference DOI: 10.1016/j.neurol.2023.01.672 QMRO: qmroHref Dobson R (2023). Family planning and multiple sclerosis. nameOfConference DOI: 10.1016/S1474-4422(22)00426-4 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82424 Krysko KM, Dobson R, Alroughani R et al. (2023). Family planning considerations in people with multiple sclerosis. nameOfConference DOI: 10.1016/S1474-4422(22)00426-4 QMRO: qmroHref Dobson R, Jacobs B, Marshall C (2023). Polygenic risk score prediction of Multiple Sclerosis in individuals of South Asian ancestry. nameOfConference DOI: 10.1093/braincomms/fcad041 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82423 Dobson R (2023). Menopause in women with multiple sclerosis: clinical symptoms, therapeutic considerations and possible impact on the course of the disease. nameOfConference DOI: 10.12968/bjnn.2023.19.Sup1.S34 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83643 Dobson R (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis (MS) during pregnancy and breastfeeding: a systematic review and Delphi consensus. nameOfConference DOI: 10.1177/13524585221148094 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83644 Iyer P, Dobson R (2023). Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies. nameOfConference DOI: 10.1007/s40120-022-00421-0 QMRO: qmroHref Kuri A, Vickaryous N, Awad A et al. (2023). Vitamin D genetic risk scores in multiple sclerosis. nameOfConference DOI: 10.1007/s00415-022-11466-4 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82470 Teelucksingh S, Govind RM, Dobson R et al. (2023). Treating Vestibular Migraine When Pregnant and Postpartum: Progress, Challenges and Innovations. nameOfConference DOI: 10.2147/IJWH.S371491 QMRO: qmroHref Noyce A (2022). The association between anti-epileptic drugs and incident Parkinson’s disease in UK Biobank. nameOfConference DOI: 10.1001/jamaneurol.2022.4699 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82500 Dreyer-Alster S, Achiron A, Giovannoni G et al. (2022). No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study. nameOfConference DOI: 10.1038/s41598-022-26409-2 QMRO: qmroHref Dobson R (2022). Social determinants of health and their impact in multiple sclerosis. nameOfConference DOI: 10.1038/s41582-022-00735-5 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80535 Simpson-Yap S, Pirmani A, Kalincik T et al. (2022). Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity. nameOfConference DOI: 10.1212/NXI.0000000000200021 QMRO: qmroHref Dobson R, Bove R (2022). In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk. nameOfConference DOI: 10.1212/WNL.0000000000201242 QMRO: qmroHref Dobson R, Bove R (2022). In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk.. nameOfConference DOI: 10.1212/WNL.0000000000201242 QMRO: qmroHref Simpson-Yap S, Pirmani A, De Brouwer E et al. (2022). Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. nameOfConference DOI: 10.1016/j.msard.2022.104072 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80518 Jacobs BM, Peter M, Giovannoni G et al. (2022). Towards a global view of multiple sclerosis genetics. nameOfConference DOI: 10.1038/s41582-022-00704-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80522 Hone L, Jacobs BM, Marshall C et al. (2022). Age-specific effects of childhood body mass index on multiple sclerosis risk. nameOfConference DOI: 10.1007/s00415-022-11161-4 QMRO: qmroHref Allen-Philbey K, Stennett A, Begum T et al. (2022). Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2022.104022 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79446 Foote IF, Jacobs BM, Mathlin G et al. (2022). The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study. nameOfConference DOI: 10.1016/j.neurobiolaging.2022.02.016 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79699 Bove R, Hellwig K, Pasquarelli N et al. (2022). Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants. nameOfConference DOI: 10.1016/j.msard.2022.103963 QMRO: qmroHref Tallantyre EC, Scurr MJ, Vickaryous N et al. (2022). Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2022.103937 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79178 Tur C, Dubessy AL, Otero-Romero S et al. (2022). The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021. nameOfConference DOI: 10.1177/13524585211069068 QMRO: qmroHref Dobson R, Tanasescu R, Gran B (2022). Editorial: Preventing multiple sclerosis. nameOfConference DOI: 10.3389/fneur.2022.982411 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80121 Dobson R, Rog D, Ovadia C et al. (2022). Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. nameOfConference DOI: 10.1136/pn-2022-003426 QMRO: qmroHref Dobson R (2022). Preventing Multiple Sclerosis - from evidence to action. nameOfConference DOI: doi QMRO: qmroHref Rivas C, Anand K, Wu AFW et al. (2022). Lessons From the COVID-19 Pandemic to Improve the Health, Social Care, and Well-being of Minoritized Ethnic Groups With Chronic Conditions or Impairments: Protocol for a Mixed Methods Study. nameOfConference DOI: 10.2196/38361 QMRO: qmroHref Judge-Clayden F, Iyer P, Williams A et al. (2022). Multiple sclerosis, disease modifying therapies and pregnancy. nameOfConference DOI: 10.12968/bjnn.2022.18.sup3.s22 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80524 Jensen M, Jacobs B, Dobson R et al. (2022). Lower lymphocyte count is associated with increased risk of Parkinson’s disease. nameOfConference DOI: 10.1136/jnnp-2022-abn.306 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78813 Belete D, Jacobs BM, Bestwick JP et al. (2022). Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study. nameOfConference DOI: 10.1136/jnnp-2022-abn.21 QMRO: qmroHref Dobson R (2022). Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS). nameOfConference DOI: 10.1016/j.msard.2022.103894 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78457 Baker D, MacDougall A, Kang AS et al. (2022). Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?. nameOfConference DOI: 10.1093/cei/uxab015 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78814 Simonet C, Bestwick J, Jitlal M et al. (2022). Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population. nameOfConference DOI: 10.1001/jamaneurol.2022.0003 QMRO: qmroHref Marshall CR, Noyce AJ, Neligan A et al. (2022). Brain health: The hidden casualty of a humanitarian crisis. nameOfConference DOI: 10.1016/j.lanepe.2022.100374 QMRO: qmroHref Bothongo PLK, Jitlal M, Parry E et al. (2022). Dementia risk in a diverse population: A single-region nested case-control study in the East End of London. nameOfConference DOI: 10.1016/j.lanepe.2022.100321 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75791 Vukusic S, Dobson R, Bove RM et al. (2022). Données de grossesses chez des femmes recevant de l’ocrelizumab pour le traitement de la sclérose en plaques. nameOfConference DOI: 10.1016/j.neurol.2022.02.383 QMRO: qmroHref Dobson R (2022). Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. nameOfConference DOI: 10.1177/2F20552173221104918 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78456 Dobson R (2022). Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study. nameOfConference DOI: 10.3389/fneur.2022.799531 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77920 Noyce A (2022). No evidence for association between polygenic risk of Multiple Sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants. nameOfConference DOI: 10.1177/2F13524585221075744 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76333 Baker D, MacDougall A, Kang AS et al. (2022). Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?. nameOfConference DOI: 10.1093/cei/uxab015 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76161 Hone L, Giovannoni G, Dobson R et al. (2022). Predicting Multiple Sclerosis: Challenges and Opportunities. nameOfConference DOI: 10.3389/fneur.2021.761973 QMRO: qmroHref Dobson R, Chung K (2022). Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary. nameOfConference DOI: 10.1177/13524585211069922 QMRO: qmroHref Huxford B, Haque T, Joseph AB et al. (2022). Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity. nameOfConference DOI: 10.1002/mds.28829 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74651 Dobson R, Marshall C, Noyce A (2022). Social determinants of neurological disease: tackling inequalities. nameOfConference DOI: 10.1016/S1474-4422(22)00005-9 QMRO: qmroHref Satukijchai C, Mariano R, Messina S et al. (2022). Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom.. nameOfConference DOI: 10.1001/jamanetworkopen.2021.42780 QMRO: qmroHref Hartmann M, Fenton N, Dobson R (2022). Development of Bayesian Network for Multiple Sclerosis Risk Factor Interaction Analysis. nameOfConference DOI: 10.1007/978-3-031-20837-9_2 QMRO: qmroHref Camera V, Messina S, Elhadd KT et al. (2022). Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. nameOfConference DOI: 10.1136/jnnp-2021-327206 QMRO: qmroHref Baker D (2021). CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2021.103448 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75590 Dobson R, Craner M, Waddingham E et al. (2021). Optimise: MS study protocol: A pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. nameOfConference DOI: 10.1136/bmjopen-2021-050176 QMRO: qmroHref Geys L, Parciak T, Pirmani A et al. (2021). The Multiple Sclerosis Data Alliance Catalogue Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources. nameOfConference DOI: 10.7224/1537-2073.2021-006 QMRO: qmroHref Dobson R, Baker D, Kang A et al. (2021). COVID-19 vaccine response in people with multiple sclerosis. nameOfConference DOI: 10.1002/ana.26251 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74690 Hone L, Jacobs B, Noyce A et al. (2021). Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75629 Stennett A, Allen-Philbey K, Begum T et al. (2021). An evaluation of remote monitoring in people with MS during the COVID-19 pandemic. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75538 Bove R, Pasquarelli N, Borriello F et al. (2021). B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO). nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75631 Dobson R, Bove R, Borriello F et al. (2021). Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75637 Ostrem B, Anderson A, Conway S et al. (2021). Pregnancy outcomes and peripartum disease activity in moderately and severely disabled women with MS. nameOfConference DOI: doi QMRO: qmroHref Hellwig K, Pasquarelli N, Borriello F et al. (2021). Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study). nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75640 Vickaryous N, Asardag AN, Chance R et al. (2021). Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75630 Simpson-Yap S, Pirmani A, De Brouwer E et al. (2021). Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75636 Hartmann M, Fenton N, Dobson R (2021). Using Bayesian networks to understand multiple sclerosis risk factor interactions. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75627 Foote I, Jacobs B, Watson C et al. (2021). W26. A MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF MODIFIABLE RISK FOR ALZHEIMER'S DISEASE: 269 LOCI ASSOCIATED WITH BRAIN HEALTH. nameOfConference DOI: 10.1016/j.euroneuro.2021.08.115 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75837 Hone L, Jacobs B, Marshall C et al. (2021). Age-specific effects of childhood Body Mass Index on multiple sclerosis risk. nameOfConference DOI: 10.1101/2021.09.12.21263445 QMRO: qmroHref Yam C, Rog D, Ford H et al. (2021). UK variance in DMT advice and prescribing in MS and pregnancy: impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines. nameOfConference DOI: 10.1016/j.msard.2021.103272 QMRO: qmroHref Kuri A, Jacobs BM, Leddy S et al. (2021). Evaluation of remote assessments for multiple sclerosis in an in-home setting. nameOfConference DOI: 10.1016/j.msard.2021.103125 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73142 Huxford B, Haque T, Joseph A et al. (2021). HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74691 Jacobs BM, Noyce AJ, Bestwick J et al. (2021). Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study. nameOfConference DOI: 10.1212/NXI.0000000000001007 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70963 Jacobs BM, Smets I, Giovannoni G et al. (2021). Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis. nameOfConference DOI: 10.1177/1352458520969941 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69385 Dobson R (2021). Differing Impact of DMT on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?. nameOfConference DOI: 10.1212/WNL.0000000000012356 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/72400 Leavitt VM, Dobson R, Svennigsson A (2021). Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress. nameOfConference DOI: 10.1212/WNL.0000000000012101 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71702 Garjani A, Hunter R, Law G et al. (2021). Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register. nameOfConference DOI: 10.1177/13524585211020435 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71706 Dobson R, Hellwig K (2021). Use of disease-modifying drugs during pregnancy and breastfeeding. nameOfConference DOI: 10.1097/WCO.0000000000000922 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71028 Dobson R, ALLEN-PHILBEY K, Giovannoni G et al. (2021). Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2021.103028 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71833 Garjani A, Middleton RM, Hunter R et al. (2021). COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. nameOfConference DOI: 10.1016/j.msard.2021.102939 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71868 Taylor TRP, Galloway J, Davies R et al. (2021). Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis. nameOfConference DOI: 10.1212/NXI.0000000000000992 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71493 Jensen MP, Jacobs BM, Dobson R et al. (2021). Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease. nameOfConference DOI: 10.1002/ana.26034 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70059 Krysko KM, Bove R, Dobson R et al. (2021). Treatment of Women with Multiple Sclerosis Planning Pregnancy. nameOfConference DOI: 10.1007/s11940-021-00666-4 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74543 Jitlal M, Amirthalingam G, Karania T et al. (publicationYear). The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017. nameOfConference DOI: 10.3233/JAD-210089 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70919 Dobson R, Fenton N, Hartmann M (2021). Current Review and Next Steps for Artificial intelligence in Multiple Sclerosis risk research. nameOfConference DOI: 10.1016/j.compbiomed.2021.104337 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71187 Foote I, Jacobs B, Mathlin G et al. (2021). The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study. nameOfConference DOI: 10.1101/2021.02.23.21252211 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/72648 Thomson A, Dobson R, Baker D et al. (2021). Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families. nameOfConference DOI: 10.1016/j.msard.2020.102624 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70066 Evangelou N, Garjani A, Dasnair R et al. (2021). Self-diagnosed COVID-19 in people with multiple sclerosis: A community-based cohort of the UK MS Register. nameOfConference DOI: 10.1136/jnnp-2020-324449 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67162 Bothongo PL, Jitlal M, Parry E et al. (2020). Ethnic and socioeconomic determinants of dementia risk: A nested case‐control study in the population of East London. nameOfConference DOI: 10.1002/alz.037869 QMRO: qmroHref Garjani A, Hunter R, Nicholas R et al. (2020). Anxiety affects the general well-being of people with ms during the COVID-19 pandemic more than the infection itself. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69804 Garjani A, Evangelou N, Das Nair R et al. (2020). COVID-19 in people with MS: a large community-based study of the UK MS register. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69805 Taylor T, Luis J, Dobson R et al. (2020). Demographics of multiple sclerosis associated uveitis at moorfields eye hospital. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69807 Taylor T, Galloway J, Adam R et al. (2020). Demyelinating events following initiation of anti-tnf alpha therapy in the british society for rheumatology biologics registry in rheumatoid arthritis. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69808 Jacobs B, Noyce A, Bestwick J et al. (2020). Gene-environment interactions in multiple sclerosis: a uk biobank study. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69809 Vickaryous N, Jitlal M, Jacobs BM et al. (2020). Remote testing of vitamin D levels across the UK MS population—A case control study. nameOfConference DOI: 10.1371/journal.pone.0241459 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69546 Vickaryous N, Garjani A, Jacobs B et al. (2020). Vitamin D levels in the UK MS population and COVID-19 susceptibility. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69841 Auger SD, Jacobs BM, Dobson R et al. (2020). Big data, machine learning and artificial intelligence: a neurologist's guide.. nameOfConference DOI: 10.1136/practneurol-2020-002688 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67605 Auger S, Jacobs B, Dobson R et al. (2020). Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide. nameOfConference DOI: 10.1136/practneurol-2020-002688 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67242 Jacobs B, Belete D, Bestwick J et al. (2020). Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank. nameOfConference DOI: 10.1136/jnnp-2020-323646 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66809 Leddy S, Dobson R (2020). Multiple sclerosis. nameOfConference DOI: 10.1016/j.mpmed.2020.06.008 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67140 Belete D, Jacobs B, Bestwick J et al. (2020). Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Giovannoni G, Cuzick J (publicationYear). Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment. nameOfConference DOI: 10.1093/ije/dyaa151 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66806 Dobson R (publicationYear). MS, pregnancy and COVID-19. nameOfConference DOI: 10.1177/1352458520949152 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66821 Jacobs B, Taylor T, Awad A et al. (2020). Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis. nameOfConference DOI: 10.1093/braincomms/fcaa119 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65644 Taylor TR, Jacobs BM, Giovannoni G et al. (2020). Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study. nameOfConference DOI: 10.1016/j.msard.2020.102209 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66030 Peeters LM, Parciak T, Walton C et al. (2020). COVID-19 in people with multiple sclerosis: A global data sharing initiative.. nameOfConference DOI: 10.1177/1352458520941485 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66201 Reyes S, Ramsay M, Ladhani S et al. (2020). Protecting people with multiple sclerosis through vaccination. nameOfConference DOI: 10.1136/practneurol-2020-002527 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68522 Krysko KM, Graves JS, Dobson R et al. (2020). Sex effects across the lifespan in women with multiple sclerosis. nameOfConference DOI: 10.1177/1756286420936166 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67928 Kuri A, Jacobs BM, Vickaryous N et al. (2020). Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. nameOfConference DOI: 10.1186/s12889-020-09049-x QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65285 Dobson R, Jokubaitis V, Giovannoni G (2020). Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis. nameOfConference DOI: 10.1016/j.msard.2020.102241 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64764 Dobson R, Mowry EM (2020). Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis.. nameOfConference DOI: 10.1212/WNL.0000000000009369 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65298 Leddy S, Jacobs BM, Giovannoni G et al. (2020). To examine the impact of Multiple Sclerosis on bone health and explore mechanisms for this association.. nameOfConference DOI: doi QMRO: qmroHref Leddy S, Jacobs B, Giovannoni G et al. (2020). Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68234 Jacobs B, Giovannoni G, Dobson R (2020). Environmental exposures associated with Multiple Sclerosis: a UK Biobank study. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68240 Dobson R, Jitlal M, Marshall CR et al. (2020). Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk. nameOfConference DOI: 10.1002/ana.25688 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62858 Dobson R, Jacobs B, Giovannoni G et al. (publicationYear). Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors. nameOfConference DOI: 10.1177/1352458520907901 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/63739 Jokubaitis VG, Dobson R (2020). Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.. nameOfConference DOI: 10.1212/WNL.0000000000009063 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68388 Jokubaitis V, Dobson R (publicationYear). Family planning is the second most relevant factor for treatment decisions after disease activity. nameOfConference DOI: 10.1177/1352458520907902 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/63008 Dobson R, Noyce A, Giovannoni G et al. (2020). BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study. nameOfConference DOI: 10.1212/NXI.0000000000000662 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62737 Jacobs BM, Giovannoni G, Cuzick J et al. (2019). Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors. nameOfConference DOI: 10.1177/1352458520907901 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67272 Dobson R, Jitlal M, Marshall C et al. (2019). Obesity is not associated with MS in a socially and ethnically diverse population. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66396 Vickaryous N, Jitlal M, Middleton R et al. (2019). Vitamin D levels in the UK MS population. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66719 DOBSON R (2019). Visibility and representation of women in multiple sclerosis research. nameOfConference DOI: 10.1212/WNL.0000000000007276 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56468 Dobson R, Dassan P, Roberts M et al. (2019). UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines.. nameOfConference DOI: 10.1136/practneurol-2018-002060 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54858 Waubant E, Amezcua L, Sicotte N et al. (2018). Gender Inequities in the Multiple Sclerosis Community: A Call for Action. nameOfConference DOI: 10.1002/ana.25359 QMRO: qmroHref Dobson R (2018). Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution'.. nameOfConference DOI: 10.1177/1352458518807053 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/51423 Dobson R, Giovannoni G (2018). Multiple Sclerosis - a review.. nameOfConference DOI: 10.1111/ene.13819 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/48023 Thomson A, Aldam R, Giovannoni G et al. (2018). Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65723 Dobson R, Cock HR, Brex P et al. (2018). Vitamin D supplementation. nameOfConference DOI: 10.1136/practneurol-2017-001720 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/51003 Middleton RM, Rodgers WJ, Giovannoni G et al. (2017). A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64994 Dobson R, Kuhle J, Middeldorp J et al. (2017). Epstein-Barr-negative MS: a true phenomenon?. nameOfConference DOI: 10.1212/NXI.0000000000000318 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/34427 Dobson R, Ramagopalan S, Topping J et al. (2016). A Risk Score for Predicting Multiple Sclerosis.. nameOfConference DOI: 10.1371/journal.pone.0164992 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18832 Collins CDE, Ivry B, Bowen JD et al. (2016). A comparative analysis of Patient-Reported Expanded Disability Status Scale tools. nameOfConference DOI: 10.1177/1352458515616205 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54862 Binks S, Dobson R (2016). Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.. nameOfConference DOI: 10.1007/s11914-016-0320-5 QMRO: qmroHref Dobson R, Alvares D (2016). The difficulties with vitamin B12. nameOfConference DOI: 10.1136/practneurol-2015-001344 QMRO: qmroHref Topping J, Dobson R, Lapin S et al. (2016). The effects of intrathecal rituximab on biomarkers in multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2016.01.001 QMRO: qmroHref Davis AG, Dobson R, Kaninia S et al. (2016). Atraumatic needles for lumbar puncture: Why haven’t neurologists changed?. nameOfConference DOI: 10.1136/practneurol-2014-001055 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10032 Disanto G, Adiutori R, Dobson R et al. (2016). Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. nameOfConference DOI: 10.1136/jnnp-2014-309690 QMRO: qmroHref Binks S, Dobson R (2015). Established, new and future disease modifying therapies for MS. nameOfConference DOI: 10.1002/pnp.399 QMRO: qmroHref Kuhle J, Gaiottino J, Leppert D et al. (2015). Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. nameOfConference DOI: 10.1136/jnnp-2013-307454 QMRO: qmroHref Kuhle J, Gaiottino J, Leppert D et al. (2015). Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.. nameOfConference DOI: 10.1136/jnnp-2013-307454 QMRO: qmroHref Kuhle J, Disanto G, Dobson R et al. (2015). Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. nameOfConference DOI: 10.1177/1352458514568827 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/7011 Leddy S, Fowler AJ, Giovanonni G et al. (2014). DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS. nameOfConference DOI: 10.1136/jnnp-2014-309236.134 QMRO: qmroHref Cooper R, Doshi A, Harris P et al. (2014). IMMUNOCOMPETENT PML—AN IMMUNOLOGICAL SCOTOMA?. nameOfConference DOI: 10.1136/jnnp-2014-309236.112 QMRO: qmroHref Disanto G, Dobson R, Pakpoor J et al. (2014). Genetic predictors of multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Disanto G, Dobson R, Pakpoor J et al. (2014). The refinement of genetic predictors of multiple sclerosis. nameOfConference DOI: 10.1371/journal.pone.0096578 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54861 Shribman SE, Torsney K, Noyce AJ et al. (2014). A service development study of the assessment and management of fracture risk in Parkinson's disease. nameOfConference DOI: doi QMRO: qmroHref Torsney KM, Noyce AJ, Doherty KM et al. (2014). A systematic review and meta-analysis of fracture risk in Parkinson's disease. nameOfConference DOI: doi QMRO: qmroHref Torsney KM, Noyce AJ, Doherty KM et al. (2014). Bone health in Parkinson's disease: A systematic review and meta-analysis. nameOfConference DOI: doi QMRO: qmroHref Davis A, Dobson R, Kaninia S et al. (2014). Change practice now! Using atraumatic needles to prevent post lumbar puncture headache. nameOfConference DOI: 10.1111/ene.12307 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12000 Dobson R, Rudick RA, Turner B et al. (2014). Assessing treatment response to interferon-beta Is there a role for MRI?. nameOfConference DOI: 10.1212/WNL.0000000000000036 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/43428 Dobson R, Rudick RA, Turner B et al. (2014). Assessing treatment response to interferon-β :Is there a role for MRI?. nameOfConference DOI: 10.1212/WNL.0000000000000036 QMRO: qmroHref Shribman S, Torsney KM, Noyce AJ et al. (2014). A service development study of the assessment and management of fracture risk in Parkinson's disease. nameOfConference DOI: 10.1007/s00415-014-7333-8 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/42544 Torsney KM, Noyce AJ, Doherty KM et al. (2014). Bone health in Parkinson's disease: A systematic review and meta-analysis. nameOfConference DOI: 10.1136/jnnp-2013-307307 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/37224 Raffel J, Dobson R, Gafson A et al. (2014). Multiple sclerosis therapy and Epstein-Barr virus antibody titres. nameOfConference DOI: 10.1016/j.msard.2013.12.004 QMRO: qmroHref Hadavi S, Baker MD, Dobson R (2014). Sustained-release fampridine in Multiple Sclerosis. nameOfConference DOI: 10.1016/j.msard.2013.06.003 QMRO: qmroHref Leddy S, Hadavi S, Carren AM et al. (2013). A novel internet-based method of capturing outcomes in multiple sclerosis.. nameOfConference DOI: 10.1136/jnnp-2013-306573.9 QMRO: qmroHref Hadavi S, Giovannoni G, Dobson R (2013). A service development audit of fampridine use in ms.. nameOfConference DOI: 10.1136/jnnp-2013-306573.178 QMRO: qmroHref Dobson R, Topping J, Davis A et al. (2013). Cerebrospinal fluid and urinary biomarkers in multiple sclerosis. nameOfConference DOI: 10.1111/ane.12119 QMRO: qmroHref Hadavi S, Shribman S, Nagy A et al. (2013). The bradykinesia-akinesia incoordination test: a simple objective test in multiple sclerosis.. nameOfConference DOI: 10.1136/jnnp-2013-306573.184 QMRO: qmroHref Dobson R, McMillan A, Kung K et al. (2013). Think outside the box, collapse the box, and take a sharp knife to it!. nameOfConference DOI: 10.1136/jnnp-2013-306573.173 QMRO: qmroHref Dobson R, Topping J, Ramagopalan S et al. (2013). Towards an endophenotype in multiple sclerosis.. nameOfConference DOI: 10.1136/jnnp-2013-306573.31 QMRO: qmroHref Leddy S, Hadavi S, McCarren A et al. (2013). A novel internet-based method of capturing outcomes in multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Giovannoni G (2013). Bone health in multiple sclerosis: should we be doing more?. nameOfConference DOI: 10.2217/nmt.13.46 QMRO: qmroHref Kuhle J, Dobson R, Bestwick JP et al. (2013). Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS. nameOfConference DOI: doi QMRO: qmroHref James E, Dobson R, Kuhle J et al. (2013). The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.. nameOfConference DOI: 10.1177/1352458513489756 QMRO: qmroHref Leddy S, Hadavi S, McCarren A et al. (2013). Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.. nameOfConference DOI: 10.1007/s00415-013-7004-1 QMRO: qmroHref Gaiottino J, Norgren N, Dobson R et al. (2013). Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases. nameOfConference DOI: 10.1371/journal.pone.0075091 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54859 Dobson R, Ramagopalan S, Davis A et al. (2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.. nameOfConference DOI: 10.1136/jnnp-2012-304695 QMRO: qmroHref Dobson R, Giovannoni G (2013). Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.. nameOfConference DOI: 10.1007/s00415-012-6790-1 QMRO: qmroHref Dobson R, Yarnall A, Noyce AJ et al. (2013). Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes.. nameOfConference DOI: 10.1136/practneurol-2012-000435 QMRO: qmroHref Pakpoor J, Handel AE, Giovannoni G et al. (2013). Correction: Meta-analysis of the relationship between multiple sclerosis and migraine (PLoS ONE). nameOfConference DOI: 10.1371/annotation/274e5ef1-79aa-48f7-af62-0594d5c1354e QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/5223 Dobson R, Giovannoni G, Ramagopalan S (2013). The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.. nameOfConference DOI: 10.1136/jnnp-2012-303934 QMRO: qmroHref Dobson R, Leddy SG, Gangadharan S et al. (2013). Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.. nameOfConference DOI: 10.1136/bmjopen-2012-002508 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54863 Dobson R, Ramagopalan SV, Giovannoni G (2013). Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?. nameOfConference DOI: 10.1586/ern.13.13 QMRO: qmroHref Pakpoor J, Disanto G, Gerber JE et al. (2013). The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.. nameOfConference DOI: 10.1177/1352458512449682 QMRO: qmroHref Dobson R, Ramagopalan S, Davis A et al. (2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude. nameOfConference DOI: 10.1136/jnnp-2012-304695 QMRO: qmroHref Dobson R, Topping J, Giovannoni G (2013). Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.. nameOfConference DOI: 10.1002/jmv.23446 QMRO: qmroHref Evdoshenko E, Maslyanskiy A, Lapin S et al. (2013). Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.. nameOfConference DOI: 10.1155/2013/748127 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68755 Dobson R, Giovannoni G, Ramagopalan S (2013). The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude. nameOfConference DOI: 10.1136/jnnp-2012-303934 QMRO: qmroHref Dobson R, Ramagopalan S, Giovannoni G (2012). Bone health and multiple sclerosis.. nameOfConference DOI: 10.1177/1352458512453362 QMRO: qmroHref Dobson R, Rudick RA, Giovannoni G (2012). CAN WE RELIABLY USE MRI TO MONITOR TREATMENT RESPONSE IN PATIENTS ON INTERFERON beta: A SYSTEMATIC REVIEW AND META-ANALYSIS. nameOfConference DOI: 10.1136/jnnp-2012-304200a.127 QMRO: qmroHref Dobson R, Ramagopalan S, Giovannoni G (2012). Risk of fractures in patients with multiple sclerosis: A populationbased cohort study. nameOfConference DOI: 10.1212/01.wnl.0000422676.74031.07 QMRO: qmroHref Davis A, Dobson R, Espasandin M et al. (2012). Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Ramagopalan S, Giovannoni G (2012). Osteoporosis and fracture risk in multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Topping J, Evdoshenko E, Dobson R et al. (2012). The effects of intrathecal rituximab on biomarkers in MS. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Topping J, Davis A et al. (2012). Urinary and CSF biomarkers in multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Pakpoor J, Handel AE, Giovannoni G et al. (2012). Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine. nameOfConference DOI: 10.1371/journal.pone.0045295 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/54864 Dobson R, Ramagopalan S, Giovannoni G (2012). The effect of gender in clinically isolated syndrome (CIS): a meta-analysis.. nameOfConference DOI: 10.1177/1352458511426740 QMRO: qmroHref Dobson R (2012). Urine: An under-studied source of biomarkers in multiple sclerosis?. nameOfConference DOI: 10.1016/j.msard.2012.01.002 QMRO: qmroHref Disanto G, Sandve GK, Berlanga-Taylor AJ et al. (2012). Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells. nameOfConference DOI: 10.1371/journal.pone.0032281 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/4924 Dobson R, Meier UC, Schmierer K et al. (2012). DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK?. nameOfConference DOI: 10.1136/jnnp-2011-301993.173 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/7015 Raffel J, Dobson R, Giovannoni G (2012). THE EFFECT OF NATALIZUMAB AND INTERFERON-beta ON URINARY FREE LIGHT CHAINS AND ANTI-EBV NUCLEAR ANTIGEN-1 ANTIBODIES IN RELAPSING REMITTING MULTIPLE SCLEROSIS. nameOfConference DOI: 10.1136/jnnp-2011-301993.190 QMRO: qmroHref Dobson R, Giovannoni G (2012). WHY CAN'T I WIN ANY MORE?. nameOfConference DOI: 10.1136/jnnp-2011-301993.200 QMRO: qmroHref Dobson R, Meier UC, Marta M et al. (2011). Vitamin D deficiency - do we follow our own advice?. nameOfConference DOI: 10.7861/clinmedicine.11-6-521 QMRO: qmroHref Dobson R, Meier UC, Schmierer K et al. (2011). Do siblings have markers of multiple sclerosis risk?. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Lawden M (2011). Melanoma associated retinopathy and how to understand the electroretinogram.. nameOfConference DOI: 10.1136/practneurol-2011-000061 QMRO: qmroHref Maghzi A-H, Marta M, Bosca I et al. (2011). Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?. nameOfConference DOI: 10.1016/j.pathophys.2010.04.003 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68754 Handel AE, Williamson AJ, Disanto G et al. (2011). Smoking and Multiple Sclerosis: An Updated Meta-Analysis. nameOfConference DOI: 10.1371/journal.pone.0016149 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/5463 Meier UC, Giovannoni G (2011). More to come: humoral immune responses in MS. nameOfConference DOI: 10.1016/j.jneuroim.2011.09.009 QMRO: qmroHref Dobson R, Feldmann M, Thompson AJ et al. (2010). INCREASED URINARY FREE IMMUNOGLOBULIN LIGHT CHAIN EXCRETION IN PATIENTS WITH MULTIPLE SCLEROSIS. nameOfConference DOI: 10.1136/jnnp.2010.226340.159 QMRO: qmroHref Dobson R, Lawden M (2010). CP1 Darkness visible. nameOfConference DOI: 10.1136/jnnp.2010.226340.66 QMRO: qmroHref Ramagopalan SV, Dobson R, Meier UC et al. (2010). Multiple sclerosis: risk factors, prodromes, and potential causal pathways.. nameOfConference DOI: 10.1016/S1474-4422(10)70094-6 QMRO: qmroHref Dobson R, Miller RF, Palmer HE et al. (2010). Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.. nameOfConference DOI: 10.1016/j.jneuroim.2010.01.012 QMRO: qmroHref Supervision Benjamin Jacobs – Genetic determinants of multiple sclerosis risk in diverse ancestral backgrounds (MRC) Brook Huxford – Remote biomarkers in Parkinson’s disease (Wolfson) Morghan Hartman – Using Bayesian methodology to understand complex disease (PanBayesian) Heather Mah – Using social capital to understand PPI in MS (Horne Family Foundation) Imogen Collier – Menopause and multiple sclerosis (to start Sept 2022)